2023 Australian Psychedelic Retrospective
By Sam Young In 2023, the world of psychedelic research and therapy witnessed a paradigm shift, marking an era where ancient wisdom and modern
By Sam Young In 2023, the world of psychedelic research and therapy witnessed a paradigm shift, marking an era where ancient wisdom and modern
Image credit: Michael Garfield and Alex Grey artworks digitally combined By Melissa Warner and Jasmine Blom 5-MeO-DMT is a unique and compelling member of the
Exploring the PRISM and DanceWize partnership By Stephanie Tzanetis Psychedelic assisted-psychotherapy (PAP), as the name indicates, is a therapy session aided by psychedelic compounds. By
By Josh Miosku & Melissa Warner A cultural and scientific exploration of a little known non-traditional psychedelic. Salvia divinorum, Latin for sage of the diviners,
Media Release: 16th December 2021 TGA Rescheduling of Psilocybin and MDMA: Delegate’s Final Decision On December 15th, the Therapeutic Goods Administration (TGA) announced
Media Release: 1st of October 2021 TGA Rescheduling of Psilocybin and MDMA Independent Expert Review Panel Report Yesterday, the Australian Therapeutic Goods Administration (TGA)
Current and future Australian research in this space will offer a crucial pathway for the provision of psychedelic-assisted therapy and to develop our understanding of consciousness itself. Notably, none of the current research into psychedelic-assisted treatments for mental illness in Australia is receiving government funding. With your support, our research paves the way for establishing evidence-informed psychedelic-assisted treatments